Navigation Links
Nektar Therapeutics Announces Fourth Quarter and Year-End 2007 Financial Results
Date:2/27/2008

ollaborative agreement, net, is comprised of

the following (in thousands):

Three and Twelve-Months

Ended December 31, 2007

Pfizer termination settlement

payment received 135,000

Exubera Inhaler Manufacturing and

Supply Agreement Termination

Tech Group (13,765)

Bespak (18,598)

102,637

Settlement of assets and

liabilities related to Pfizer (23,459)

Gain on termination of

collaborative agreements, net 79,178

(3) For the three-months ended December 31, 2007, there were

approximately 578 dilutive shares which did not change earnings per

share.

NEKTAR THERAPEUTICS

CONSOLIDATED BALANCE SHEETS

(In thousands)

(unaudited)

ASSETS December 31, 2007 December 31, 2006(1)

Current assets:

Cash and cash equivalents $76,293 $63,760

Short-term investments 406,060 394,880

Accounts receivable, net of

allowance 21,637 47,148

Inventory 12,187 14,656

Other current assets 7,106 14,595

Total current assets 523,283 535,039

Long-term investments - 8,337

Property and equipment, net
'/>"/>

SOURCE Nektar Therapeutics
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine news :

1. Nektar to Announce Third Quarter 2007 Financial Results on Wednesday, November 7, 2007, After the Close of U.S. Financial Markets
2. Nektar Therapeutics Announces Third Quarter 2007 Financial Results
3. Nektars Leading PEGylation and Pulmonary Technology Platforms Featured at R&D Day in New York
4. Nektar Announces Agreement With Baxter to Develop New PEGylated Therapeutics for Hemophilia
5. Nektar Therapeutics President and CEO, Howard W. Robin, to Present at Merrill Lynch 19th Global Pharmaceutical, Biotechnology & Medical Device Conference in New York City
6. Nektar to Announce 2007 Year-End Financial Results on Wednesday, February 27, 2008, After Close of U.S.-Based Financial Markets
7. Prime Therapeutics Receives TIPPS Certification
8. Adams Respiratory Therapeutics to Celebrate 10th Anniversary of its Incorporation on September 12
9. Transition Therapeutics Announces Fiscal 2007 Year End Financial Results
10. Lorus Therapeutics announces election of three new Directors and appoints a new Chairman
11. Deane F. Johnson Center for Neurotherapeutics to Launch First Mobile Medical Unit on October 4th
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/20/2014)... CA (PRWEB) August 20, 2014 If old ... found a cure for it. With extensive research on HGH ... named ‘MetroMD’ claims to have perfected the art of rubbing ... a brand new younger look with their revolutionary anti-aging hormone ... of the 21st century fountain of youth, the MD of ...
(Date:8/20/2014)... (PRWEB) August 20, 2014 The ... a five-year, $1.24 million Science Education Partnership Award ... to support NAHN’s collaborative project with the Hispanic ... Health Careers. , This collaborative NIH R25 program ... cultural and linguistic diversity among health professionals by ...
(Date:8/20/2014)... Utah (PRWEB) August 20, 2014 Today, ... new information on open enrollment for 2015. , According ... insurance coming up in November, employees are encouraged to ... seeking coverage in 2015, the open enrollment period will ... During open enrollment 2015 individuals can purchase a new ...
(Date:8/20/2014)... 2014 Attendees of Seedstock’s 3rd Annual ... at Los Angeles’ first multi-faceted food production business incubator ... blossoming 1.5-acre high school campus urban farming operation in ... in the L.A. Art District. , The field trip, ... agriculture, will kick off Seedstock’s “Reintegrating Ag: Local Food ...
(Date:8/20/2014)... MA (PRWEB) August 20, 2014 Verndale ... annual Inc. 500|5000 list; an exclusive list ranking the ... list are ranked according to their yearly percentage revenue ... the 8th time on the Inc. 5000 list where ... Technology Company, Verndale offers its clients a wide range ...
Breaking Medicine News(10 mins):Health News:MetroMD Offers Revolutionary Anti-aging Hormone Therapy in Hollywood Area 2Health News:National Association of Hispanic Nurses (NAHN) Receives Five-Year Federal Grant from the National Institutes of Health (NIH) 2Health News:National Association of Hispanic Nurses (NAHN) Receives Five-Year Federal Grant from the National Institutes of Health (NIH) 3Health News:Seedstock Sustainable Agriculture Conference’s Urban Farm Field Trip to Offer First Look at Los Angeles’ Premier Food Business Incubator 2Health News:Seedstock Sustainable Agriculture Conference’s Urban Farm Field Trip to Offer First Look at Los Angeles’ Premier Food Business Incubator 3Health News:For the 8th Time, Verndale Has Been Honored on the Inc. 5000 List 2
... Inc. (Nasdaq: CADX ) announced today that it ... a private placement approximately 12 million shares of the Company,s ... million additional shares of the Company,s common stock, for aggregate ... paid for the common stock, $7.13 per share, is equal ...
... 4:00 PM ET - VALENCIA, Calif., Feb. 17 /PRNewswire-FirstCall/ ... ) today reported financial results for the fourth quarter ... of 2008, total operating expenses were $81.8 million, compared ... Research and development (R&D) expenses increased by $2.0 million ...
... bulk of cases, study finds, , , TUESDAY, Feb. 17 (HealthDay ... loss also have eye disorders, a new study has found. ... ear or to the nerves that link the ear to ... according to background information in the study. Half of all ...
... announced today that it has,received certification of its full ... Standards by the Jefferson School of,Population Health. , ... 10 Quality and Safety Standards in,March of 2007 with ... as its Clinical Advisory Board. A condition of CCA,membership ...
... HotHead Technologies, Inc. today,announced that the technology they ... Kennesaw State University researchers as an early,warning ... "It,s exciting news that research from a university as ... verify much earlier than we anticipated, in,the preliminary stages ...
... Light Press, LLC announces the audio edition of "That,s ... written by co-authors Lil Ingram and Marlene Lee, and ... of HOPE is available in MP3 format at no ... will also be available via the website for the ...
Cached Medicine News:Health News:Cadence Pharmaceuticals to Raise $86.6 Million in a Private Placement of Common Stock 2Health News:Cadence Pharmaceuticals to Raise $86.6 Million in a Private Placement of Common Stock 3Health News:MannKind Corporation Reports Fourth Quarter and Full Year 2008 Financial Results 2Health News:MannKind Corporation Reports Fourth Quarter and Full Year 2008 Financial Results 3Health News:MannKind Corporation Reports Fourth Quarter and Full Year 2008 Financial Results 4Health News:MannKind Corporation Reports Fourth Quarter and Full Year 2008 Financial Results 5Health News:MannKind Corporation Reports Fourth Quarter and Full Year 2008 Financial Results 6Health News:MannKind Corporation Reports Fourth Quarter and Full Year 2008 Financial Results 7Health News:Eye Problems, Hearing Loss May Be Linked 2Health News:RediClinic Meets Strict Quality and Safety Standards for Retail Clinics 2Health News:RediClinic Meets Strict Quality and Safety Standards for Retail Clinics 3Health News:RediClinic Meets Strict Quality and Safety Standards for Retail Clinics 4Health News:HotHead Technologies' Heat Sensor Shows Exciting Potential by Kennesaw State University Researchers 2Health News:'That's My Hope' Audio Edition Released 2Health News:'That's My Hope' Audio Edition Released 3
(Date:8/20/2014)... , Aug. 20, 2014  Quantum Materials Corporation ... sets of patent families from Bayer Technology Services GmbH, ... for Bayer AG of Leverkusen, Germany ... provide broad intellectual property protection for advances ... quantum dot (QD) manufacturing. In addition, the Bayer ...
(Date:8/20/2014)... Glenmark Pharmaceuticals S.A. (GPSA), ... India (GPL), announces the discovery and initiation of ... candidate, GBR 1302, a HER2xCD3 bispecific antibody. GBR ... Biologics Research Centre located in La Chaux-de-Fonds, ... on Glenmark,s innovative BEAT antibody technology platform which ...
(Date:8/20/2014)... 20, 2014 Phase I Trial ... US  KalVista Pharmaceuticals ("KalVista"), an ophthalmology company ... announces that it has begun a Phase I, First ... KVD001, for the treatment of DME. The study,s Principal ... Eye Institute, Joslin Diabetes Center; Harvard Medical School Department ...
Breaking Medicine Technology:Quantum Materials Acquires Bayer Technology Services Quantum Dot Manufacturing and Quantum Dot Solar Cell Patents 2Quantum Materials Acquires Bayer Technology Services Quantum Dot Manufacturing and Quantum Dot Solar Cell Patents 3Quantum Materials Acquires Bayer Technology Services Quantum Dot Manufacturing and Quantum Dot Solar Cell Patents 4Glenmark Enters Oncology With the Discovery and Initiation of IND Enabling Studies of an Innovative Bispecific Antibody 2Glenmark Enters Oncology With the Discovery and Initiation of IND Enabling Studies of an Innovative Bispecific Antibody 3KalVista Pharmaceuticals Announces Start of Clinical Development for Novel Treatment for Diabetic Macular Edema 2KalVista Pharmaceuticals Announces Start of Clinical Development for Novel Treatment for Diabetic Macular Edema 3KalVista Pharmaceuticals Announces Start of Clinical Development for Novel Treatment for Diabetic Macular Edema 4
... Information Systems ("SIS"), a leader in perioperative ... leadership in achieving clinical, financial, and operational goals ... the company,s annual client conference, the 2012 SIS ... systems exemplifying the innovative use of information technology ...
... 2012 Top leaders representing America,s advanced medical ... public policy issues affecting job creation and medical innovation and ... billion medical device tax set to begin in January 2013. ... Renacci (R-Ohio) joined Walter M Rosebrough, president and CEO of ...
Cached Medicine Technology:Surgical Information Systems Recognizes Clients for Financial, Clinical, and Operational Improvements 2Surgical Information Systems Recognizes Clients for Financial, Clinical, and Operational Improvements 3Surgical Information Systems Recognizes Clients for Financial, Clinical, and Operational Improvements 4AdvaMed & BioOhio Discuss MedTech Impact on Ohio's Economy, Job Creation 2AdvaMed & BioOhio Discuss MedTech Impact on Ohio's Economy, Job Creation 3
... your expectations with state of the art ... customized to meet the needs of your ... can be upgraded to grow with you. ... database management, it is easy to see ...
... ultimate flexibility by allowing you to determine ... display. Wall-mount anywhere in the room. Further ... laptop, touch screen tablet, industrial PC, desktop ... multi-function patient tower provides more power and ...
... capabilities combined with ease of use make ... its class. Ideal for office or hospital-based ... for Uroflowmetry, cystometry, leak point pressure, or ... available which make the OM-5 flexible enough ...
... combined with ease of use make the ... class. Ideal for office or hospital-based urodynamics, ... Uroflowmetry, cystometry, leak point pressure, or urethral ... which make the OM-5 flexible enough to ...
Medicine Products: